138 related articles for article (PubMed ID: 1467027)
1. Streptokinase resistance: when might streptokinase administration be ineffective?
Buchalter MB; Suntharalingam G; Jennings I; Hart C; Luddington RJ; Chakraverty R; Jacobson SK; Weissberg PL; Baglin TP
Br Heart J; 1992 Nov; 68(5):449-53. PubMed ID: 1467027
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
[TBL] [Abstract][Full Text] [Related]
3. Streptokinase neutralisation titres up to 866 days after intravenous streptokinase for acute myocardial infarction.
Patel S; Jalihal S; Dutka DP; Morris GK
Br Heart J; 1993 Aug; 70(2):119-21. PubMed ID: 8038019
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.
Lynch M; Littler WA; Pentecost BL; Stockley RA
Br Heart J; 1991 Aug; 66(2):139-42. PubMed ID: 1883664
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres.
Lee HS; Yule S; McKenzie A; Cross S; Reid T; Davidson R; Jennings K
Eur Heart J; 1993 Dec; 14(12):1640-3. PubMed ID: 8131761
[TBL] [Abstract][Full Text] [Related]
6. Antistreptokinase titres after intravenous streptokinase.
Jalihal S; Morris GK
Lancet; 1990 Jan; 335(8683):184-5. PubMed ID: 1967665
[TBL] [Abstract][Full Text] [Related]
7. Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions.
Laisaar T; Pullerits T
Chest; 2003 Feb; 123(2):432-5. PubMed ID: 12576362
[TBL] [Abstract][Full Text] [Related]
8. Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase.
Lee HS; Cross S; Davidson R; Reid T; Jennings K
Eur Heart J; 1993 Jan; 14(1):84-9. PubMed ID: 8432298
[TBL] [Abstract][Full Text] [Related]
9. Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction.
Rosenschein U; Lenz R; Radnay J; Ben Tovim T; Rozenszajn LA
Isr J Med Sci; 1991 Oct; 27(10):541-5. PubMed ID: 1955306
[TBL] [Abstract][Full Text] [Related]
10. Streptokinase antibodies inhibit reperfusion during thrombolytic therapy with streptokinase in acute myocardial infarction.
Juhlin P; Boström PA; Torp A; Bredberg A
J Intern Med; 1999 May; 245(5):483-8. PubMed ID: 10363749
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy.
Elliott JM; Cross DB; Cederholm-Williams SA; White HD
Am J Cardiol; 1993 Mar; 71(8):640-5. PubMed ID: 8447258
[TBL] [Abstract][Full Text] [Related]
12. A rapid agglutination assay to detect anti-streptokinase antibodies.
McRedmond JP; Mulvihill NT; Kane M; Burke B; Aloul B; Forde T; Walsh M; Fitzgerald DJ
Ir J Med Sci; 2004; 173(4):204-10. PubMed ID: 16323615
[TBL] [Abstract][Full Text] [Related]
13. [Anti-streptokinase antibodies].
Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
[TBL] [Abstract][Full Text] [Related]
14. Antistreptokinase antibodies before and after streptokinase therapy in patients with acute myocardial infarction from areas endemic for streptococcal infection and influence on reperfusion rates.
Shaila G; Chandrashekhar YS; Kumar N; Ganguly NK; Anand IS
Am J Cardiol; 1994 Jul; 74(2):187-9. PubMed ID: 8023789
[No Abstract] [Full Text] [Related]
15. Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction.
Abuosa AM; Akhras F; Sorour K; El-Said G; El-Tobgy S; Kinsara AJ
Saudi Med J; 2005 Jun; 26(6):934-6. PubMed ID: 15983677
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the reactivity of natural and mutated streptokinase with total antistreptokinase antibodies in human sera.
Bandehpour M; Sharifnia Z; Mohajeri N; Taherkhani M; Koochaki A; Yarian F; Seyyed N; Shirvani R; Pakzad P; Saadat H; Kazemi B
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):734-8. PubMed ID: 23080363
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic treatment and proteinuria.
Lynch M; Hoffmann NV; Aroney CN
Br Heart J; 1995 Oct; 74(4):354-7. PubMed ID: 7488445
[TBL] [Abstract][Full Text] [Related]
18. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction.
Squire IB; Lawley W; Fletcher S; Holme E; Hillis WS; Hewitt C; Woods KL
Eur Heart J; 1999 Sep; 20(17):1245-52. PubMed ID: 10454976
[TBL] [Abstract][Full Text] [Related]
19. Anti-streptokinase antibodies and streptokinase resistance in an Aboriginal population in northern Australia.
Urdahl KB; Mathews JD; Currie B
Aust N Z J Med; 1996 Feb; 26(1):49-53. PubMed ID: 8775528
[TBL] [Abstract][Full Text] [Related]
20. Platelet activity and antibody titers after exposure to streptokinase or streptococcal infection.
Courval M; Palisaitis DA; Diodati JG; Lesperance B; Pharand C
Thromb Res; 2003; 111(4-5):243-9. PubMed ID: 14693171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
